{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:50:05Z","timestamp":1790394605443,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00284-019-01654-3","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T09:16:51Z","timestamp":1551086211000},"page":"520-526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Changes in Clostridium (Clostridioides) difficile PCR-Ribotype Distribution and Antimicrobial Resistance in a German Tertiary Care Hospital Over the Last 10\u00a0Years"],"prefix":"10.1007","volume":"76","author":[{"given":"E.","family":"Piepenbrock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Stelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Jazmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"issue":"1","key":"1654_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/gmic.26854","volume":"5","author":"DN Gerding","year":"2014","unstructured":"Gerding DN, Johnson S, Rupnik M, Aktories K (2014) Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5(1):15\u201327. https:\/\/doi.org\/10.4161\/gmic.26854","journal-title":"Gut Microbes"},{"issue":"1","key":"1654_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ng.2478","volume":"45","author":"M He","year":"2013","unstructured":"He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D\u2019Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TD (2013) Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet 45(1):109\u2013113. https:\/\/doi.org\/10.1038\/ng.2478","journal-title":"Nat Genet"},{"issue":"11","key":"1654_CR3","first-page":"E071115 071111","volume":"12","author":"NH Zaiss","year":"2007","unstructured":"Zaiss NH, Weile J, Ackermann G, Kuijper E, Witte W, Nuebel U (2007) A case of Clostridium difficile-associated disease due to the highly virulent clone of Clostridium difficile PCR ribotype 027, March 2007 in Germany. Euro Surveill 12(11):E071115 071111","journal-title":"Euro Surveill"},{"issue":"9","key":"1654_CR4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1055\/s-0029-1245269","volume":"48","author":"A Jansen","year":"2010","unstructured":"Jansen A, Kleinkauf N, Weiss B, Zaiss NH, Witte W, Bornhofen B, Kist M, von Eichel-Streiber C, Neumann M, Michels H, Eckmanns T (2010) Emergence of clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics. Z Gastroenterol 48(9):1120\u20131125. https:\/\/doi.org\/10.1055\/s-0029-1245269","journal-title":"Z Gastroenterol"},{"issue":"12","key":"1654_CR5","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S1473-3099(14)70991-0","volume":"14","author":"KA Davies","year":"2014","unstructured":"Davies KA, Longshaw CM, Davis GL, Bouza E, Barbut F, Barna Z, Delmee M, Fitzpatrick F, Ivanova K, Kuijper E, Macovei IS, Mentula S, Mastrantonio P, von Muller L, Oleastro M, Petinaki E, Pituch H, Noren T, Novakova E, Nyc O, Rupnik M, Schmid D, Wilcox MH (2014) Underdiagnosis of Clostridium difficile across Europe: the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID). Lancet Infect Dis 14(12):1208\u20131219. https:\/\/doi.org\/10.1016\/S1473-3099(14)70991-0","journal-title":"Lancet Infect Dis"},{"key":"1654_CR6","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00426-18","author":"N Jazmati","year":"2018","unstructured":"Jazmati N, Kirpal E, Piepenbrock E, Stelzer Y, Vehreschild M, Seifert H (2018) Evaluation of the use of rectal swabs for the laboratory diagnosis of Clostridium difficile infection. J Clin Microbiol. https:\/\/doi.org\/10.1128\/JCM.00426-18","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1654_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ijmm.2015.08.035","volume":"305","author":"L Muller von","year":"2015","unstructured":"von Muller L, Mock M, Halfmann A, Stahlmann J, Simon A, Herrmann M (2015) Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons. Int J Med Microbiol 305(7):807\u2013813. https:\/\/doi.org\/10.1016\/j.ijmm.2015.08.035","journal-title":"Int J Med Microbiol"},{"key":"1654_CR8","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.29.30294","author":"KA Davies","year":"2016","unstructured":"Davies KA, Ashwin H, Longshaw CM, Burns DA, Davis GL, Wilcox MH, Group Es (2016) Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point-prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.ES.2016.21.29.30294","journal-title":"Euro Surveill"},{"key":"1654_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.anaerobe.2016.04.006","volume":"40","author":"M Arvand","year":"2016","unstructured":"Arvand M, Bettge-Weller G (2016) Clostridium difficile ribotype 027 is not evenly distributed in Hesse. Germany Anaerobe 40:1\u20134. https:\/\/doi.org\/10.1016\/j.anaerobe.2016.04.006","journal-title":"Germany Anaerobe"},{"issue":"3","key":"1654_CR10","doi-asserted-by":"publisher","first-page":"309.e301","DOI":"10.1016\/j.cmi.2017.08.014","volume":"24","author":"MJT Crobach","year":"2018","unstructured":"Crobach MJT, Voor In \u2018t Holt AF, Knetsch CW, van Dorp SM, Bras W, Harmanus C, Kuijper EJ, Vos MC (2018) An outbreak of Clostridium difficile infections due to new PCR ribotype 826: epidemiologic and microbiologic analyses. Clin Microbiol Infect 24(3):309.e301\u2013309.e304. https:\/\/doi.org\/10.1016\/j.cmi.2017.08.014","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1654_CR11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/jac\/dkl398","volume":"58","author":"D Drudy","year":"2006","unstructured":"Drudy D, Quinn T, O\u2019Mahony R, Kyne L, O\u2019Gaora P, Fanning S (2006) High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile. J Antimicrob Chemother 58(6):1264\u20131267. https:\/\/doi.org\/10.1093\/jac\/dkl398","journal-title":"J Antimicrob Chemother"},{"key":"1654_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/genomeA.00073-15","author":"T Gaulton","year":"2015","unstructured":"Gaulton T, Misra R, Rose G, Baybayan P, Hall R, Freeman J, Turton J, Picton S, Korlach J, Gharbia S, Shah H (2015) Complete genome sequence of the hypervirulent bacterium Clostridium difficile strain G46, ribotype 027. Genome Announc. https:\/\/doi.org\/10.1128\/genomeA.00073-15","journal-title":"Genome Announc"},{"key":"1654_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.10.008","author":"J Freeman","year":"2017","unstructured":"Freeman J, Vernon J, Pilling S, Morris K, Nicholson S, Shearman S, Longshaw C, Wilcox MH, Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes study g (2017) The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011\u20132014. Clin Microbiol Infect. https:\/\/doi.org\/10.1016\/j.cmi.2017.10.008","journal-title":"Clin Microbiol Infect"},{"key":"1654_CR14","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/j.ijid.2012.05.595","volume":"16","author":"S Neupert","year":"2012","unstructured":"Neupert S, Lindner M, Bethge A, Ruf BR, Gruenewald T (2012) \u2018MIC-creep\u2019 in Clostridium difficile? Int J Infect Dis 16:e427. https:\/\/doi.org\/10.1016\/j.ijid.2012.05.595","journal-title":"Int J Infect Dis"},{"issue":"10","key":"1654_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1017\/S0950268811002627","volume":"140","author":"M Reil","year":"2012","unstructured":"Reil M, Hensgens MP, Kuijper EJ, Jakobiak T, Gruber H, Kist M, Borgmann S (2012) Seasonality of Clostridium difficile infections in Southern Germany. Epidemiol Infect 140(10):1787\u20131793. https:\/\/doi.org\/10.1017\/S0950268811002627","journal-title":"Epidemiol Infect"},{"key":"1654_CR16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2807\/ese.13.49.19057-en","volume":"13","author":"S Borgmann","year":"2008","unstructured":"Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B (2008) Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill 13:(49)","journal-title":"Euro Surveill"},{"issue":"2","key":"1654_CR17","doi-asserted-by":"publisher","first-page":"e0118150","DOI":"10.1371\/journal.pone.0118150","volume":"10","author":"WN Fawley","year":"2015","unstructured":"Fawley WN, Knetsch CW, MacCannell DR, Harmanus C, Du T, Mulvey MR, Paulick A, Anderson L, Kuijper EJ, Wilcox MH (2015) Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. PloS ONE 10(2):e0118150. https:\/\/doi.org\/10.1371\/journal.pone.0118150","journal-title":"PloS ONE"},{"issue":"Pt 11","key":"1654_CR18","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1099\/jmm.0.47714-0","volume":"57","author":"A Indra","year":"2008","unstructured":"Indra A, Huhulescu S, Schneeweis M, Hasenberger P, Kernbichler S, Fiedler A, Wewalka G, Allerberger F, Kuijper EJ (2008) Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol 57(Pt 11):1377\u20131382. https:\/\/doi.org\/10.1099\/jmm.0.47714-0","journal-title":"J Med Microbiol"},{"issue":"5","key":"1654_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/jac\/dki357","volume":"56","author":"J Freeman","year":"2005","unstructured":"Freeman J, Stott J, Baines SD, Fawley WN, Wilcox MH (2005) Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital. J Antimicrob Chemother 56(5):988\u2013989. https:\/\/doi.org\/10.1093\/jac\/dki357","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"1654_CR20","doi-asserted-by":"publisher","first-page":"E266","DOI":"10.1111\/j.1469-0691.2012.03907.x","volume":"18","author":"LT Erikstrup","year":"2012","unstructured":"Erikstrup LT, Danielsen TK, Hall V, Olsen KE, Kristensen B, Kahlmeter G, Fuursted K, Justesen US (2012) Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. Clin Microbiol Infect 18(8):E266\u2013E272. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03907.x","journal-title":"Clin Microbiol Infect"},{"key":"1654_CR21","volume-title":"Guidelines for ATC classification and DDD assignment 2018","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2017","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2017) Guidelines for ATC classification and DDD assignment 2018, 21st\u00a0edn. WHO Collaborating Centre for Drug Statistics Methodology, Oslo","edition":"21"},{"issue":"9","key":"1654_CR22","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1086\/592257","volume":"47","author":"A Goorhuis","year":"2008","unstructured":"Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C, Notermans DW, Bergwerff AA, Dekker FW, Kuijper EJ (2008) Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 47(9):1162\u20131170. https:\/\/doi.org\/10.1086\/592257","journal-title":"Clin Infect Dis"},{"key":"1654_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.anaerobe.2016.06.002","volume":"41","author":"BY Tsai","year":"2016","unstructured":"Tsai BY, Ko WC, Chen TH, Wu YC, Lan PH, Chen YH, Hung YP, Tsai PJ (2016) Zoonotic potential of the Clostridium difficile RT078 family in Taiwan. Anaerobe 41:125\u2013130. https:\/\/doi.org\/10.1016\/j.anaerobe.2016.06.002","journal-title":"Anaerobe"},{"issue":"11","key":"1654_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1469-0691.2007.01824.x","volume":"13","author":"F Barbut","year":"2007","unstructured":"Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I, European Study Group on Clostridium d (2007) Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13(11):1048\u20131057. https:\/\/doi.org\/10.1111\/j.1469-0691.2007.01824.x","journal-title":"Clin Microbiol Infect"},{"issue":"9759","key":"1654_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","volume":"377","author":"MP Bauer","year":"2011","unstructured":"Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, Group ES (2011) Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759):63\u201373. https:\/\/doi.org\/10.1016\/S0140-6736(10)61266-4","journal-title":"Lancet"},{"issue":"7","key":"1654_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1469-0691.2012.03853.x","volume":"18","author":"MP Hensgens","year":"2012","unstructured":"Hensgens MP, Keessen EC, Squire MM, Riley TV, Koene MG, de Boer E, Lipman LJ, Kuijper EJ, European Society of Clinical M, Infectious Diseases Study Group for Clostridium d (2012) Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect 18(7):635\u2013645. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03853.x","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"1654_CR27","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1128\/JCM.02250-16","volume":"55","author":"Z Peng","year":"2017","unstructured":"Peng Z, Jin D, Kim HB, Stratton CW, Wu B, Tang YW, Sun X (2017) Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing. J Clin Microbiol 55(7):1998\u20132008. https:\/\/doi.org\/10.1128\/JCM.02250-16","journal-title":"J Clin Microbiol"},{"issue":"11","key":"1654_CR28","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1128\/AAC.43.11.2607","volume":"43","author":"F Barbut","year":"1999","unstructured":"Barbut F, Decre D, Burghoffer B, Lesage D, Delisle F, Lalande V, Delmee M, Avesani V, Sano N, Coudert C, Petit JC (1999) Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrobial Agents Chemother 43(11):2607\u20132611","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"1654_CR29","doi-asserted-by":"publisher","first-page":"e53757","DOI":"10.1371\/journal.pone.0053757","volume":"8","author":"T Lynch","year":"2013","unstructured":"Lynch T, Chong P, Zhang J, Hizon R, Du T, Graham MR, Beniac DR, Booth TF, Kibsey P, Miller M, Gravel D, Mulvey MR, Canadian Nosocomial Infection Surveillance P (2013) Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate. PLoS ONE 8(1):e53757. https:\/\/doi.org\/10.1371\/journal.pone.0053757","journal-title":"PLoS ONE"},{"issue":"5","key":"1654_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jac\/48.5.741","volume":"48","author":"JS Brazier","year":"2001","unstructured":"Brazier JS, Fawley W, Freeman J, Wilcox MH (2001) Reduced susceptibility of Clostridium difficile to metronidazole. J Antimicrob Chemother 48(5):741\u2013742","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"1654_CR31","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/jac\/dkn313","volume":"62","author":"SD Baines","year":"2008","unstructured":"Baines SD, O\u2019Connor R, Freeman J, Fawley WN, Harmanus C, Mastrantonio P, Kuijper EJ, Wilcox MH (2008) Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 62(5):1046\u20131052. https:\/\/doi.org\/10.1093\/jac\/dkn313","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1654_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/jac\/dks420","volume":"68","author":"I Moura","year":"2013","unstructured":"Moura I, Spigaglia P, Barbanti F, Mastrantonio P (2013) Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes. J Antimicrob Chemother 68(2):362\u2013365. https:\/\/doi.org\/10.1093\/jac\/dks420","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"1654_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3201\/eid1604.090859","volume":"16","author":"NH Zaiss","year":"2010","unstructured":"Zaiss NH, Witte W, Nubel U (2010) Fluoroquinolone resistance and Clostridium difficile, Germany. Emerg Infect Dis 16(4):675\u2013677. https:\/\/doi.org\/10.3201\/eid1604.090859","journal-title":"Emerg Infect Dis"},{"issue":"11\u201312","key":"1654_CR34","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00103-012-1556-6","volume":"55","author":"L M\u00fcller von","year":"2012","unstructured":"von M\u00fcller L, Halfmann A, Herrmann M (2012) Current data and trends on the development of antibiotic resistance of Clostridium difficile. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55(11\u201312):1410\u20131417. https:\/\/doi.org\/10.1007\/s00103-012-1556-6","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"3","key":"1654_CR35","doi-asserted-by":"publisher","first-page":"248.e249","DOI":"10.1016\/j.cmi.2014.09.017","volume":"21","author":"J Freeman","year":"2015","unstructured":"Freeman J, Vernon J, Morris K, Nicholson S, Todhunter S, Longshaw C, Wilcox MH, Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes\u2019 Study G (2015) Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes. Clin Microbiol Infect 21(3):248.e249\u2013248.e216. https:\/\/doi.org\/10.1016\/j.cmi.2014.09.017","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1654_CR36","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1128\/AAC.45.8.2348-2353.2001","volume":"45","author":"G Ackermann","year":"2001","unstructured":"Ackermann G, Tang YJ, Kueper R, Heisig P, Rodloff AC, Silva J Jr, Cohen SH (2001) Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob Agents Chemother 45(8):2348\u20132353. https:\/\/doi.org\/10.1128\/AAC.45.8.2348-2353.2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"1654_CR37","first-page":"24","volume":"111","author":"M Toepfer","year":"2014","unstructured":"Toepfer M, Magnusson C, Noren T, Hansen I, Iveroth P, Offenbartl K (2014) Insidious and widespread outbreak of Clostridium difficile. Changed cleaning procedures and frequent evaluations cut infection rates in half. Lakartidningen 111(1\u20132):24\u201327","journal-title":"Lakartidningen"},{"issue":"12","key":"1654_CR38","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1469-0691.2009.03098.x","volume":"15","author":"MJ Crobach","year":"2009","unstructured":"Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15(12):1053\u20131066. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.03098.x","journal-title":"Clin Microbiol Infect"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00284-019-01654-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-019-01654-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-019-01654-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T14:47:49Z","timestamp":1662994069000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00284-019-01654-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1654"],"URL":"https:\/\/doi.org\/10.1007\/s00284-019-01654-3","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"22 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"N.J. has received funding from Maria-Pesch foundation for this research project and payment for lectures from MSD Sharp & Dohme and travel support from IMDx (Qiagen), outside the submitted work. N.J. and E.P. have received payment for clinical study supervision from DaVolterra, outside the submitted work. F.B has received consultant fees from MSD, outside the submitted work. All other authors declare that they have no conflicts of interest .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}